Bio Japan 2021 Highlights: The Commercialization of iPS Cells and the Key to Improving Clinical Trials
One of the most critical international biotechnology conferences, Bio Japan, invited professor Shinya Yamanaka over the Regenerative Medicine Japan to share the application of regenerative medicine and the latest developments in induced pluripotent stem (iPS) cells. Professor Shinya Yamanaka is a 2012 Physiology or Medicine Nobel Prize winner, and his research mainly focuses on iPS cells.
It's free! Log in now to read